Treatment of cerebral palsy with botulinum toxin A: functional benefit and reduction of disability. Three case reports

Pediatr Rehabil. 1997 Oct-Dec;1(4):235-7. doi: 10.3109/17518429709167364.

Abstract

Three patients with cerebral palsy are described suffering, respectively, of pes equinus, spasm of the m. teres major and flexion spasm of the hand, who were treated with botulinum toxin A. These patients demonstrate not only the local reduction of the muscular hyperactivity following treatment with botulinum toxin A but also the potential functional benefit resulting from such a treatment. Thus, local intramuscular injection of botulinum toxin A in children with cerebral palsy should be considered as part of a multidisciplinary treatment concept, since reduction of the disability and the functional improvements could have high impact on daily living activities.

Publication types

  • Case Reports

MeSH terms

  • Activities of Daily Living
  • Adolescent
  • Botulinum Toxins, Type A / administration & dosage
  • Botulinum Toxins, Type A / therapeutic use*
  • Cerebral Palsy / physiopathology
  • Cerebral Palsy / therapy*
  • Contracture / therapy
  • Equinus Deformity / therapy
  • Female
  • Gait / physiology
  • Hand / physiopathology
  • Humans
  • Injections, Intramuscular
  • Joint Dislocations / therapy
  • Male
  • Muscle Spasticity / therapy
  • Neuromuscular Agents / administration & dosage
  • Neuromuscular Agents / therapeutic use*
  • Shoulder Joint / physiopathology
  • Sleep / physiology
  • Walking / physiology

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A